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Whooping cough is the prototype of diseases ofthe respiratory tract in which ad-
herence plays a central role in the pathogenesis of infection . The bacteria, Bordetella
pertussis, are noninvasive, remaining localized to the cilia of the respiratory mucosal
surface throughout the 4-6 wk of disease. Such prolonged colonization restricted
topographically to a single host cell type suggests a highly specific bacterial-host rec-
ognition system(s) . Two secreted proteins ofB pertussis have been identified as adhesins
for human ciliated cells: the filamentous hemagglutinin (FHA)' and pertussis toxin
(PT) (1) . Both bacterial surface-associated and cell-free adhesins have been shown
to associate specifically with ciliated cells and promote the adherence ofB. pertussis
(1) . Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus it!
￿
enzae (2) also flu
appear to be able to bind the B . pertussis adhesins to their surfaces, indicating that
the interaction between bacterial surface and adhesin is not highly specific . Thus,
the interaction that confers the species and topographical stringency to the natural
disease must be inherent in the interaction between the adhesinsand host cell receptor.
Since the disease is virtually 100% contagious (3), the receptor must be acommon
feature of the highly differentiated human ciliarymembrane . Early studies have sug-
gested that the receptor is carbohydrate in nature by virtue ofthe staining character-
istics of material spanning the space between ciliary and bacterial membranes and
the sensitivity of adherence to treatment of ciliated cells with periodate (4) . This
study characterizes the chemical nature of receptors for B. pertussis adhesins . mAbs
recognizing this receptorwere then shown to interrupt adherence to human ciliated
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cells. This is the first demonstration of the potential contribution of anti-receptor
antibodies to the therapy and prevention of respiratory disease.
Materials and Methods
Bacterial Strains and Cultivation Conditions.
￿
Virulent strains Br (clinical isolate [4]) and BP338
(derivative of Tohama I [5]) were grown on Bordet-Gengou agar (lot 689592; Difco Labora-
tories Inc., Detroit, MI) containing 157o sheep blood and 1% glycerol for 48 h, were trans-
ferred to Stainer Scholte medium for 48 h, harvested into Medium 199S (M. A. Bioproducts,
Walkersville, MD), and adjusted to a concentration of 5 x 109 B. pertussis/ml (1, 4). Then,
0.5 ml of the bacterial suspension was aliquoted into tubes containing one of the following
as listed in Tables I and II: simple carbohydrates (Sigma Chemical Co., St. Louis, MO) at
between 10' and 10_ 2 M, complex carbohydrates (Calbiochem-Behring Corp., LaJolla, CA)
at between 0.005 and 2.5 mg/ml, mAbs (purified ascites fluid, C. A. Schoenenberger, Univer-
sitat Basel, Basel, Switzerland) at between 0.03 and 160 wg protein/ml, and lectins (Sigma
Chemical Co.) at 250 wg/ml. Control organisms received no additions. All mixtures were
incubated for 30 min in a stationary water bath at 37 °C, passed three times through a 21-
gauge needle, and then exposed to ciliated cells for the adherence assay.
Radiolabeled B. pertussis strain BP338 was prepared by transfer from Bordet Gengou agar
to Stainer Scholte medium containing 15S methionine (0.07 Ci/ml, New England Nuclear,
Boston, MA) for 48 h.
Adherence Assay.
￿
The assay was performed as described previously using 0.5 ml of a sus-
pension of human ciliated epithelial cells in Medium 199S (5 x 105 cells/ml) for each test
condition (4). Respiratory epithelialcells were obtained by the brushing ofapparently normal
human trachea during bronchoscopy. For some assays, ciliated cells were pre-incubated for
30 min at 37oC with one of the above-mentioned potential inhibitors ofadherence (carbohy-
drates, antibodies, or lectins) or with Clostridium perfringens neuraminidase (200 ug/ml; Sigma
Chemical Co.). This treatment was followed by washing (250 g at 4°C), resuspension in 0.5
ml of Medium 1995, and finally, exposure to the bacteria. For all assays, organisms and ciliated
cells were incubated together for 3 h at 37oC on a tumbler. Ciliated cells were then washed
free of nonadherent bacteria over a 3-wm polycarbonate membrane filter (Nuclepore Corp.,
Pleasanton, CA), spread on a slide, and dried. Adherent bacteria were stained with a 1 :40
dilution ofbacterial fluorescent antibody (Difco Laboratories, Inc.) by a direct-antibody tech-
nique. Slides were read in a coded fashion by one of us (E. Tuomanen) (4) . Results were
expressed as the mean number of bacteria adherent to cilia on 25 cells.
Detection ofAntibody or Adhesin Binding to B. pertussis and to Ciliated Cells.
￿
For these assays,
suspensions of bacteria or ciliated cells in Medium 199S were tested independently. 109 bac-
teria (0.5 ml) or 105 ciliated cells (0.5 ml) were incubated for 30 min with potential inhibi-
tors of adherence listed in Tables I and II, then with FHA (50 ug/ml), PT (5 ug/ml) (courtesy
of Dr. J. Cowell, Bureau of Biologics, Bethesda, MD), or no addition for 30 min. Samples
were washed twice (bacteria: 10,000 g; cells: 250 g; both for 10 min at 4°C), then exposed
to 10 ul ofantibody to FHA or to PT (goat gamma globulin fraction as per reference 1, courtesy
of Dr. J. Cowell, Bureau of Biologics, Bethesda, MD) for 30 min at 37 oC. The bacteria or
cells were then washed, resuspended in 20 ul of Medium 1995, spotted onto a microscope
slide, and air dried. Antibody that bound to the bacteria or to the ciliated cellswas detected
by staining with a 1 :20 dilution offluorescein-conjugated antibody to goat Fc (Cappel Labora-
tories, Cochranville, PA). Slides were read in a coded fashion by one of us (E. Tuomanen).
Preparation of Glycoconjugate Extracts ofHuman Ciliary Membranes.
￿
Glycoconjugates were ex-
tracted from the cilia ofa 0.5 x 5-cm strip ofhuman trachea by an adaptation ofthe method
ofRamesha (6) for deciliation oftetrahymena. Ciliated cells were scraped from the cartilagenous
support into 20 ml 20 mM Tris, 10 mM EDTA, 125 mM sucrose buffer, pH 7.2. Cells were
washed free of debris (centrifuged at 300 g for 5 min) and resuspended in 80 mM acetate,
10 mM EDTA, 125 mM sucrose buffer, pH 6.8, to a final concentration of 106 cells/ml. After
incubation for 5 min, 0.2 M CaC12 was added to a final concentration of 10 mM, the mix-
ture was swirled for 10 min, and passed three times through an 18-gauge needle. This proce-
dure releases ti70% of the cilia from cell bodies as determined by light microscopy. The mix-TUOMÀNEN ET AL.
￿
269
ture was diluted in 3 vol of Tris, EDTA, sucrose buffer (as above), and whole deciliated cells
were pelleted at 480 gfor 5 min and stored in saline at 4°C . The supernatant fluidcontaining
the cilia free of cell bodies was centrifuged at 18,000 gfor 20 min, and the pellet was stored
in saline at 4°C overnight.
The ciliary membrane was extracted by an adaptation of the method ofAdoutte et a1. (7).
The ciliary membrane was removed by vortexing the ciliary pellet in freshly prepared 1 mM
Tris, 0.1 mM EDTA, pH 8.3 (Tris-EDTA), for N2 min. This suspension was centrifuged at
48,000 gm. for 30 min to recover all particulate material. The pellet obtained was suspended
in 10 mM Tris, pH 8.0, to a concentration of N5-10 mg protein ml-1 , and 0.2-0.3 ml was
layered on a sucrose step gradient consisting of 0.7 ml of 66% (wt/wt) sucrose overlaid with
1.7 ml each of 55 and 45% sucrose and 0.7 ml of 20% sucrose in 10 mM Tris, pH 8.0. The
gradient was poured and left at 4°C for N1 h before beingused. The gradient was centrifuged
in an SW 50.1 rotor (Beckman Instruments, Inc., Palo Alto, CA) at 4.5 x 104 rpm for 1.5 h
at 4°C to separate the different fractions. Ciliary membranes banded within the 45% sucrose
layer, incompletely demembranated ciliabanded within the 55% layer, and axonemes banded
at the interface of the 55 and 66% layers of sucrose. The bands were collected from the gra-
dient, checked for purity by phase-contrast microscopy, and washed by centrifugation in 20-30
vol of 10 mM Tris, pH 8.0, before gel electrophoresis or lipid extraction.
Fractions enriched in ciliary and cell body membranes were extracted for both glycolipids
and glycoproteins. Fractions were extracted three times in chloroform/methanol (C/M) 2:1.
The protein precipitate was reserved for laterexamination, while the lipid extract was evapo-
rated, re-extracted in C/M, and evaporated under a stream of nitrogen. Extracts were sub-
jected to a Folch partition in six parts C/M to one part water(8). The upper phase was har-
vested as the glycolipid fraction and repartitioned twice in chloroform/methanol/0.1 KCl
(1 :2:10). Salt was removed by passage through a Sep-Pak C18 cartridge (Waters Associates,
Milford, MA) by washing with water. Glycolipids were eluted from the cartridge with meth-
anol and C/M. The eluate was evaporated under nitrogen, resuspended, and separated by
TLC carried outon high performance thin layer chromatography plates precoated with Silica
gel 60 (Merck & Co., Rahway, NJ), and developed in chloroform/methanol/water (60:40:9
by vol) (9).
The protein precipitates ofthe cilia and cell body fractions were suspended in sample buffer
containing 2-ME and subjected to gel electrophoresis in SDS according to the method of
Laemmli (10) (3 .5% stacking gel, 10% separating gel). Proteins were then electrophoretically
transferred to nitrocellulose by the method of Towbin et al. (11) in Tris-glycine-0.01% SDS
transfer buffer. Nitrocellulose strips containing ciliary and cell body glycoproteins were in-
cubated with a 1 :1,000 dilution of mAb for 3 h, the peroxidase conjugated anti-mouse Fc
fragment (Cappel Laboratories), and finally peroxidase substrate.
Binding ofBacteria, Isolated Adhesins, or Antibodies to Chromatographed Glycosphingolipids .
￿
An
adaptation ofthe Magnani technique (12) as described by Hansson et al. (13) was used. TLC
plates containing either ciliary or cell body glycolipids, total neutral glycolipids from dog
and rat intestine, humanmeconium, or glycosphingolipid standards (lactosylcemmide, globotri-
aosylceramide, and Lea pentaglycosylceramide) (13, 14) were dried and exposed to 0.576
(wt/vol) polyisobutyl methacrylate saturated in diethyl ether. The plate was dried thoroughly
and sprayed with 1% BSA in PBS, pH 7.3, incubated for 1 h at room temperature, rinsed
with PBS, and incubated for 2 h with one of the following in 1 % BSA in 20 ml PBS: (a) a
suspension of 108 radiolabeled B. pertussis, (b) 50 pl/ml FHA or 20 ug/ml PT; or (c) 1 :1,000
dilution of anticarbohydrate antibody. The plate was washed upside down and in experiment
(a) was dried and autoradiographed using XAR5 X-ray film (Kodak) for 24 h. For experi-
ment (b), plates were incubated with 1% BSA in PBS and 11,000 goat anti-FHA or anti-PT
antibody for 3 h. The plate was then rinsed with PBS, and samples from experiments (b)
and (c) were incubated for 3 h with 1 :100 peroxidase-conjugated anti-goat Fe or anti-mouse
Fc antibody, respectively (Cappel Laboratories), were rinsed again, and were exposed to freshly
prepared peroxidase substrate (9, 13).
Chinese Hamster Ovary (CHO) Cell Assay.
￿
The CHO cell assay was performed as described
(15). Confluent monolayers, grown in flat-bottomed microtiter plates, were exposed in dupli-
cate to 5 Al of mAbs (Table 11), anti-FHA, or anti-PT for 1 h. One well of each pair was270
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exposed to 30 ng/ml PT for 30 min. The other well was washed and incubated with 5 P1
fluorescein-conjugated anti-Fcfragment for 1 h. Wellswere washed andcellular morphology
determined by light microscopy at 6 and 24 h. Fluorescence was assessed qualitatively to
determine binding of antibodies to the cell surface.
Results
The Chemical Nature oftheReceptor.
￿
The minimal receptor unit was defined using
competition assays inwhich severaltypesofagents were usedtointerferewith B. pertussis
adherence to human ciliated cells. Inhibition of adherence was quantitated upon
addition ofsimple orcomplexcarbohydrates, lectins, oranti-carbohydrate antibodies.
All sugars were tested by pre-incubating the bacteria or the ciliated cells for30 min
at 37°C with 10-2 M sugar. The sugar was then removed and adherence was as-
sessed after 3 h ofco-incubation of the bacteria and ciliated cells. Inhibition ofad-
herence was found only ifthe simple or complex carbohydrates were preincubated
with the bacteria, but not with the ciliated cell (Table I). At high concentrations
(10-z M), mannose was found to agglutinate the bacteria, causing an apparent en-
hancement ofadherence. Comparison ofthe ability ofsimple sugars ofthe six lectin
classes orsialic acid toinhibit adherenceindicatedthatgalactosewasthe single most
effective monosaccharide competitiveinhibitor. Whenadose-response curve wascon-
structed between 10' and 10- 2 M, 500 7o inhibition ofbinding occurred at 10-s M
galactose. When galactosewas added to washed ciliated cells to which bacteria had
been previously allowed to adhere, ,10_ z Mgalactose was able to elute the adherent
bacteria from ciliary tufts within 30 min. No change in the number of adherent
bacteria occurred in the presence of the other monosaccharides in Table I.
Since the pattern of competitive inhibition by monosaccharides does not neces-
sarily predict the structure ofa receptor (16), the ability ofalibrary ofcomplexcar-
bohydrates containing galactose and N-acetylated amino sugars to inhibit adher-
ence was tested. Many complex carbohydrates containing galactose in 01-4 linkage
blocked adherence (Table I). Lactose was a highly effective competitive inhibitor
ofadherence. Breast milk, thecarbohydrates ofwhich are >90% lactose, decreased
bindingto 2% ofcontrol values, while breast milk devoid oflactose did not inhibit
(91% ofcontrol binding). Lactosamines withorwithout sialic acid also blockedad-
herence. However, N-acetylgalactosamine-containing compounds with a01-3 back-
bone linkage did not block adherence. Removal ofsialic acid from ciliated cells by
neuraminidase did not decrease adherence.
Theimportance ofthegalactose-N-acetylglucosamine moiety to adherence ofB. per-
tussis to cilia was further demonstrated by testing lectins for their ability to engage
the human cell receptor and block adherence. The lectins shown in Table I were
incubatedwith bacteria or ciliated cells, andafter washing, bacterial adherence was
tested. Twoofthe sevenlectins tested decreasedadherence; inhibitionoccurred only
when the ciliated cell and not when the bacterium was incubated with the lectin.
The specificity ofthe mosteffectiveantiadherence lectin, Lotus tetragonolobus, was
fucose-al-2-galactose-01-4-N-acetylglucosamine. Reduced, but detectable, activity
was found for peanut agglutinin (recognizes fucosylated galactose 01-3 N-acetyl-
galactosamine). Thus, a common receptor structure containing part ofthe lactose
structurecould beproposed from thestudieswith thelibrary ofsimple and complex
carbohydrates and the lectins.4" .1)
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Direct Determination ofthe Binding of Whole Bacteria andPurledAdhesins to Ciliary and
Natural Carbohydrates. Glycolipids were separated by TLC and the ability of radio-
labeled whole bacteria, purified adhesins, and anti-carbohydrate antibodies to bind
to the plate was tested . Bound whole bacteria were detected by autoradiography in
the region of the TLC plate corresponding to lactosylceramide and a species of
triglycosylceramide (Fig . 1) . The purified adhesins FHA and PT, either alone or
in combination, bound to the same carbohydrate species as the whole bacteria .
Activities of the Anti-carbohydrate mAbs in Blocking Adherence .
￿
mAbs to human cell
surface glycosphingolipids with carbohydrate composition related to lactosaminewere
tested forthree properties expected of antibodies recognizingtheB . pertussis receptor :
(a)the ability to bind tohuman ciliary tuftsbut not ciliated cell bodies ; (b) the ability
TABLE II
Antiadherence Activity of Anticarbohydrate mAbst
FIGURE 1.
￿
Patternofbinding ofwholeB . perius-
sic to natural glycolipids . All panels schematically
representbinding to thesame set ofglycolipids.
(Lanes 1-3) Total non-acid glycosphingolipids of
dog intestine at 1, 2, and 10 gl, respectively.
(Lanes 4-6)Purifiedlactosyl-andglobotriaosyl-
ceramide at 1, 2, and 4and 1, 2, and 10 it] respec-
tively. (A) Radiolabeled B, pertussis whole or-
ganisms ; (B) Anisaldehyde detection of all
glycolipids .
A = [GaINAcal-+3] Gal [a1"-2Fuc]01-3G1cNAc ; Lea = Galpl-3GIcNAc [4-laFuc] ; Leb = [Fucal-+
2]Gal0l-3G1cNAc [4-1aFuc] ; Le' - gal01-4G1cNAc [3-laFucl ; LeY = [Fuca1-+2]Gal01-4G1cNAc
[3-laFucl ;U = specificity not related to A, B, H, or Lewis antigens ; GSL = glycosphingolipid .
: ( + ) Block adherence (0 BP/cell with l0 10 inoculum in standard assay) ; (-) normal adherence (>5 BP/cell
with 10 1( 'inoculum in standard assay) .










1018569-4 A, Leb IgG3 + + Cilia and cell body
1021510-69 LeY IgM + + + None
1022525-17 Lea IgG26 + + + Cilia and cell body
1022523-24 Lea IgG26 + + + Cilia
1018519-11 Lea IgGi + + + Cilia
1022575-67 Lea IgG3 + + + None
101855-3 Leab IgM - + None
1018556-4 U IgM - - None
1000593-1-3 U IgM - - None
1021SIl-28 U IgG2a - + None
1021562-71 Le't IgM - - None
1022556-58 Nonfucosylated IgG - - None





Binding of antiadherence antibodies
to chromatographically separated glycolipids of
humancilia and ciliated cell bodies . Anti-A (69.4,
poor antiadherence activity) and anti-Lea (23-
24, good antiadherence activity) antibodies were
incubated with duplicate thin layer chromato-
grams containingglycolipids extracted from cilia
(C), deciliated cell body (CB), or meconium (M).
Antibodybindingwas detected by overlaying per-
oxidase conjugated anti-mouse Fc antibody fol-
lowed by peroxidase substrate.
to bind to extracts ofhuman ciliary membranes; and (c) the ability to block adher-
ence of whole organisms and purified adhesins to cilia.
As shown in Table II, a series of antibodies recognizing the Lewis a (Lea), Leb,
orA bloodgroup antigens were effective in blocking adherenceofB. Pertussis to cilia.
Upon titration of blocking activity, the IC50 for the Lea-specific antibodies 23-24
and 19-11 was the lowest, 0.03 pg/ml, while that for the a Leb-specific antibody 69-4
was 0.5 ug/ml. Antibodies 23-24 and69-4 were chosen for furtherstudy . Thelocal-
ization of binding of antibodies 69-4 and 23-24 to ciliated cells, the latter being
the more effective antiadherence antibody, was different. Antibody 23-24 bound
to ciliaand not to ciliated cell bodies as detected by fluorescein-labeled anti-Fc anti-
body . The same antibody alsobound to adoubletofglycolipids in extracts of ciliary
but less to cell body cytoplasmic membrane (Fig. 2) ; antibody 69-4 bound to cell
body-related glycolipids. Antibody 23-24 also bound to a single ciliaryglycoprotein
(not shown) ; 69-4 did not bind . The anti-adherence antibody 23-24 bound to as
little as 1 ng of Lewis a antigen on thin layerchromatograms. Antibody 23-24 did
not crossreact with the Lewis b antigen, theH antigen (the A and B precursor),
or structural isomers of the Lewis a antigen in the TLC assay .
In addition to the ability to block adherence ofwhole B . Pertussis to cilia, mAbs
were tested for the ability to alter adhesin binding to intact ciliated cells as well as
for thephenomenon ofenhancementofadherence . Purified adhesins have been shown
to localize to the ciliary membrane (1, 17, 18). When preincubated with antibodies
23-24, 19-11, andto alesser extent 69-4, ciliated cellscouldno longer capture purified
adhesins from the medium as detected by immunofluorescence. The capture of
adhesins from the medium is known to enhance the binding of virulent B. Pertussis
to the adhesin-coated ciliated cell (1). Antibody 23-24 blocked this enhancement
phenomenon .
SincePT is an adhesin in the human ciliated cell assayin vitroand antibody 23-24
blocked its association with cilia, we tested if the antibody blocked binding ofPT
to its specific receptor on CHO cells . Even at high concentrations of antibody (5274
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mg/ml protein), a low concentration (30 ng/ml) of PT was still able to intoxicate
CHO cells as indicated by thedevelopment ofthe characteristic clustering morphology.
Discussion
The development of an in vitro assay quantitating the adherence of B . pertussis
tohuman ciliated cells hasledto the elucidation ofseveral aspectsofthe mechanism
by which this interaction is sustained for such an unusually long time in patients
with whooping cough. The bacterial side of the interaction involves two secreted
proteins, FHA and PT (1). Both are important for adherence to ciliated cells (1),
whileFHAalone appears to be sufficient foradherence to nonciliated cells (19) . Early
evidence suggested that theB . pertussis-cilia interaction was similar to that of clas-
sical mucosal pathogens, in that bacterial proteins recognized host cell carbohydrates
(4) . This report describes the nature of a family of host cell receptors on human
ciliated cells that interact with both adhesins .
Several lines of evidence indicate that part of the lactose moiety is the minimal
receptor unit forB . pertussison humancilia. Carbohydratesthatmimicked thereceptor
and blocked adherence when preincubated with the organism included galactose,
galactose (i1-4-glucose, and complex lactosamines . Substitution with sialic acid or
mannose did not alter antiadherence activity. Breast milk, in which the carbohy-
drate is >90% lactose, also was an inhibitor of adherence . Alveolar glycoprotein also
contains similar moieties, suggesting endogenous competitive inhibitors of adher-
ence occur in the distal lung where organisms are only rarely found in natural dis-
ease (17) . Importantly, the incubation ofciliated cellsbearing adherent bacteria with
high concentrations of galactosecaused elutionof the adherentB . pertussis. This sug-
gests that receptor analogs maybe candidates for adjuncts to thetherapyofB . pertussis.
Masking of the receptor on cilia was achieved by preincubation of ciliated cells
within lectins or anti-carbohydrate mAbs recognizing the galactose-glucose struc-
ture . Reagents directed against the R1-4 (and, to a lesser extent, the p1-3) configu-
ration were effective inhibitors .Awide varietyof saccharide substitutions (fucosyla-
tion, N-acetylation, etc.), wasacceptableamong inhibitors ; such permissiveness has
been shownpreviously forProprionobacteriumgranulosum andEscherichia coli adherence
to nonciliated cells (20) . This suggested that the core structure ofmany blood group
antigens such as A, B, H, and Lewis could serve as a receptor forB . pertussis, a fact
that would explain why virtually all people are susceptible to the disease . In fact,
mAbs against the Lewis a (Gal B1-3G1cNAc[4-1-a-Fuc]) and, to a lesser extent, A
or Leb antigens, were effective antibody inhibitors of adherence . These antibodies
bound to ciliated cells and, in the case of the most effective antibody (anti-Lea),
bound to cilia and not ciliated cell bodies . This is consistent with the topographic
restriction ofthe bacteria to ciliary tuftsduring natural infection . Interestingly, several
pneumococcal polysaccharides carry the lactose moiety and block adherence, sug-
gesting that anti-capsular antibody (particularly to types 14 and 19)may affect the
adherence ofB . pertussis (17) . It remainsto be shown ifprophylaxis ofcontacts might
be achieved by anti-receptor antibodies or by receptor analogs.
Bordetella demonstrate remarkable species specificity for the target host. Differ-
ences in adherence have been clearly shown to parallel the natural pattern ofdisease
(18), suggesting receptors maydiffer between infected hosts. Studies by Plotkin andBemis (21) suggest that N-acetylglucosamine is critical to the receptor of B . bron-
chiseptica in the hamster. In contrast, the receptor in swine has been characterized
as a ganglioside (22). It is possible that this discrepancy represents a similarity to
thesituationfound for Vibrio cholera, which adheres primarily to the gangliosideGMl
but less efficiently to fucosylated nonacidic carbohydrates (23, 24). In the case of
B . pertussu, gangliosides are capableofinhibitingFHA-dependent adherence to non-
ciliated tissue culture cells (J . Cowell, Bureau ofBiologics, Bethesda, MD, personal
communication) . Despite extensive effort, however, we were not able to demonstrate
a primary role for sialic acid-containing compounds in adherence ofB . pertussis to
human cilia either by competition studies or by treatment of cells with neuramini-
dase. Both FHA and PT, alone or in combination, adhered to purified lactose-
containing glycolipids on TLC plates, suggesting that this receptor can interact with
both adhesins. Since adherence to cilia involves two adhesins, FHA and PT, while
that to nonciliated cells occurs with FHA alone, it is possible that thebinding specificity
of PT masks the ganglioside specificity of FHA when human cells are the target
or that two carbohydrate specificities exist. We suggest that the latter is more likely
fortwo reasons. Fetuin andhaptoglobin notonly blockadherence but also areknown
to bind to PT sufficiently well so as to serve as ligands for purification of the toxin
by affinity chromatography (25, 26) . Fetuin does not, however, block the binding
to and intoxication ofCHO cells by PT (27). This is consistent with our finding
that although the antiadherence mAbs bound to CHO cells, they did not prevent
intoxication . PT is astructurally complex toxin, and these findings indicate that the
PT binding site promoting adherence of thewhole organism to cilia is distinct from
that associated with ADP-ribosylating activity. This does notrule outthe possibility
that binding at one site may facilitate binding at the other, since the association
of structurally similar glycolipids and glycoproteins as part ofa complex linked to
intracellular signaling systems has been described (28) .
Summary
The adherence of Bordetella pertussis to human respiratory cilia is critical to the
pathogenesis of whooping cough . To explore the development of agents that could
interrupt adherence, the structure of the receptor on the ciliary surface was inves-
tigated . Using an in vitro adherence assay to human ciliated epithelial cells, galac-
tose, lactose, and complex carbohydrates containing lactose eliminated adherence
when preincubated with the bacteria. 10-2M galactose eluted adherent bacteria
from cilia. B . pertussis and itstwo purified adhesins bound specifically to natural lactose-
containing glycolipids in a TLC assay. mAbs to eukaryotic glycoconjugates with
specificity forsubstituted galactose-glucose moieties blocked adherencewhen prein-
cubated with ciliated cells. The carbohydrates that serve as receptors forB . pertussis
on human cilia are galactose-glucose-containing glycolipids. Receptor analogs and
anti-receptor antibodies effectively block adherence ofB . pertussis to cilia and thus
should be considered candidates for therapeutic intervention against disease.
We thankM. Geller for preparation of this manuscript .
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